Abbott Alinity i Processing Module Recalled for Unlabeled Latex Subcomponent
Abbott Laboratories is recalling 1,325 Alinity i Processing Module systems due to unlabeled dry natural rubber (latex) subcomponents. Users with latex allergies may be at risk of exposure.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall involves FDA Class II classification with unlabeled latex (a common allergen) in a medical device. Following the rubric for allergen mislabeling on common allergens without reported illness, the severity is High.
Plain-English summary
Abbott Laboratories is recalling 1,325 Alinity i Processing Module systems (List Number 03R65-01). The Alinity i Processing Module is a fully automated immunoassay analyzer used in laboratory settings. The devices contain a dry natural rubber (latex) subcomponent that is not identified or labeled as containing latex.
Latex is a known allergen. Individuals with latex sensitivity or allergies may experience allergic reactions through contact with or exposure to the unlabeled latex component. Healthcare workers and laboratory personnel using these devices may be at risk if unaware of the latex presence.
The affected devices have been distributed throughout the United States and Brazil. They are identified by List Number 03R65-01 and can be located using the Serial Numbers and UDI-DI codes specified in the FDA recall notice.
Individuals or facilities using the affected Alinity i Processing Module devices should discontinue use or contact Abbott Laboratories for information about corrective actions. Those with known latex allergies should exercise caution around any recalled units.
The recalled product
- Product
- Alinity i Processing Module REF 03R65-01 The Alinity i Processing Module is a fully automated immunoassay analyzer allowing random and continuous access, as well as priority and automated retest processing using chemiluminescent microparticle immunoassay (CMIA) technology.
- Manufacturer
- Abbott Laboratories
- Hazard
- allergen-latex
- mis-labeling
Distribution
Distributed in 47 states:
- AK
- AL
- AR
- AZ
- CA
- CO
- CT
- DE
- FL
- GA
- IA
- ID
- IL
- IN
- KS
- KY
- LA
- MA
- MD
- ME
- MI
- MN
- MO
- MS
- MT
- NC
- ND
- NE
- NJ
- NM
- NV
- NY
- OH
- OK
- OR
- PA
- RI
- SC
- SD
- TN
- TX
- UT
- VA
- VT
- WA
- WI
- WV
Related recalls
Same category
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Trays Recalled Due to Quality and Efficacy Concerns
FDA (Devices) · 2026-06-03
- HighMedline Medical Convenience Kit Recalled: Wrong Syringe Type Inside
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03